Skip to main content

Share story

Science Capital

PhaSER wins $2.7M Gates grant for infectious disease drug research

PhaSER wins $2.7M Gates grant for infectious disease drug research Image: Primary
PhaSER Biomedical announced a $2.7M (£2m) Gates Foundation grant to support research into drugs for diseases including tuberculosis and malaria. The two-year award renews the Scottish biotech's participation in the Global Health Discovery Collaboratory, giving Gates-funded researchers access to its mice and expertise in how the body processes drugs. PhaSER's 8HUM mice carry human versions of the main genes that break down medicines. A University of Dundee study found that drugs behaved more like they do in patients than in ordinary mice. The grant follows a $2.3M award announced in 2024.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from The Next Web and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

BlackPeak closes €125 million for Southeast European growth investments

BlackPeak Capital announced a €125 million first close for its second Southeast Europe growth equity fund, providing capital for companies in Bulgaria, Romania, Croatia, Slovenia and Serbia. Its investment themes include e-commerce, healthcare, digitalisation and sustainability.